Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Clinical presentation and prognosis in MOG-antibody disease: a UK study

Journal article

Jurynczyk M. et al, (2017), Brain, 140, 3128 - 3138

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis

Journal article

Jurynczyk M. et al, (2017), Brain, 140, 617 - 627

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Journal article

Juryńczyk M. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 132 - 136

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

Journal article

Tackley G. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 165 - 169

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes

Journal article

Juryńczyk M. et al, (2016), Journal of Neurology, 263, 140 - 149

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Journal article

Waters P. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e89 - e89

Overlapping CNS inflammatory diseases: differentiating features of NMO and MS

Journal article

Juryńczyk M. et al, (2015), Journal of Neurology, Neurosurgery & Psychiatry, 86, 20 - 25